Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/49971
Título: Salicylate decreases production of AmpC type β-lactamases and increases susceptibility to β-lactams in a Morganella morganii clinical isolate
Autores/as: Tavío, María M. 
Perilli, Mariagrazia
Vila, Jordi
Becerro, Pino
Casañas, Lucía
Amicosante, Gianfranco
Teresa Jiménez De Anta, María
Clasificación UNESCO: 32 Ciencias médicas
320103 Microbiología clínica
Palabras clave: Multiple Antibiotic-Resistance
Enterobacter-Cloacae
Escherichia-Coli
Outer-Membrane
Expression, et al.
Fecha de publicación: 2004
Publicación seriada: FEMS Microbiology Letters 
Resumen: The effect of salicylate, a marRAB inducer, on the resistance to beta-lactams was characterized in an AmpC beta-lactamase hyperproducer Morganella morganii clinical isolate (the M1 strain). Results were compared with those of the effect of salicylate in a wild-type M. morganii strain. Salicylate induced a decreased susceptibility to nalidixic acid, norfloxacin and tetracycline and simultaneously increased the susceptibility to beta-lactams apparently due to the repression of AmpC P-lactamase synthesis in the M1 strain. Likewise, salicylate only repressed 46 kDa outer membrane protein expression in the wild-type strain, since the clinical isolate M1 did not express it.
URI: http://hdl.handle.net/10553/49971
ISSN: 0378-1097
DOI: 10.1016/j.femsle.2004.07.030
Fuente: FEMS Microbiology Letters[ISSN 0378-1097],v. 238(1), p. 139-144 (Septiembre 2004)
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.